Neil Stahl,Jamie M. Orengo,Andrew J. Murphy,Namita Gandhi,Neil Graham
申请号：
US15842868
公开号：
US20180094070A1
申请日:
2017.12.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of allergic reactions. The present invention also provides methods for enhancing the efficacy and/or safety of an allergen-specific immunotherapy (SIT) regimen. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4Rα) antagonist such as an anti-IL-4Rα antibody.
